Latest Health News
FDA Rejects Moderna's New Flu Vaccine Application
A political appointee overruled FDA scientists to reject Moderna's application for a new flu vaccine. FDA Commissioner Marty Makary faces criticism from anti-abortion Republicans over delays in reviewing mifepristone safety. This decision highlights tensions between politics and science in vaccine approvals.
Trump's EPA Revokes Climate Change as Health Threat Finding
The Trump administration revoked the 2009 EPA finding that climate change endangers public health, calling it a scam. Scientific studies confirm increasing diseases and thousands of annual deaths from warming. This undermines regulations on global warming.
WHO: Next-Generation Flu Vaccines Could Save Millions of Lives
Next-gen influenza vaccines could prevent 18 billion cases and save 6.2 million lives from 2025-2050 by offering broader protection. They may also reduce antibiotic use by 1.3 billion doses amid seasonal flu's billion cases yearly. The assessment guides investments and pandemic preparedness.
CDC Issues Level 2 Travel Advisory for Seychelles Chikungunya Outbreak
The CDC advises enhanced precautions for travelers to Seychelles due to a chikungunya virus outbreak spread by mosquitoes. This Level 2 alert urges practice of preventive measures. Chikungunya causes fever and joint pain.
FDA Approves First-of-Its-Kind Optune Pax Device for Pancreatic Cancer
The FDA approved Novocure's portable Optune Pax, delivering tumor treating fields (TTFields) to disrupt pancreatic cancer cell division. It improves survival by two months when added to chemotherapy. The non-invasive device supports home use.
Abortion Restrictions Linked to Higher Maternal Death Rates
States with stricter abortion laws since 2005 see about 16 additional maternal deaths yearly post-childbirth. Columbia University research ties restrictions on access and providers to increased mortality. Restrictions have ratcheted up significantly.
Dozens of Democrats Call for Removal of OB-GYNs from Vaccine Panel
Democrats demand removal of newly appointed OB-GYNs from a vaccine advisory panel amid concerns over expertise. The call highlights debates on panel composition. This affects public health policy.
Airglove Medical Launches v2 for Difficult IV Access
Airglove v2 warms arms to dilate veins, achieving 87.5% first-time cannulation success in oncology trials across UK hospitals. It reduces failures in 32 million annual UK cannulations. The system improves patient comfort and workflow.
CEPI Seeks $2.5 Billion for Disease Vaccine Defenses Amid Outbreaks
CEPI 3.0 aims to raise $2.5 billion to counter chikungunya, Nipah, and Marburg outbreaks challenging vaccine development. This strengthens global preparedness. Recent outbreaks underscore urgent needs.
Novartis Expands Pluvicto Radioligand to Earlier Prostate Cancer Stages
Novartis' Phase III PSMA-DC trial tests Pluvicto in oligometastatic prostate cancer for potential curative benefits. Radioligand therapies advance with multitumor programs. Investments grow in isotope supply.
FDA Approves Pembrolizumab Plus Paclitaxel for Recurrent Ovarian Cancer
The FDA approved Keytruda (pembrolizumab) with paclitaxel for PD-L1-positive recurrent ovarian cancers. This immunotherapy regimen offers new options. Approval announced recently.
RNA Breakthrough Sheds Light on Origins of Life
Researchers discovered tiny RNA molecule QT45 that self-replicates, a key step toward explaining life's origins. Evolved from random sequences via lab methods. Published in Science.